Micofluidics is more than just blood prick testing. Here, for the first time, we have compiled a database of emerging, innovative companies in microfluidics as well as established companies which just started exploring this field to showcase the commercial merits of microfluidics-related technologies. Applications range from biology to electronics, from agriculture to space systems, from tissue engineering to organ-on-a-chip, from fertility enhancement to mutation diagnostics, from food safety to polymer synthesis, from cancer research to oil shale research, from DNA sequencing to DNA modification, from point-of-care to university, from fluorescence detection to infra-red excitation, from magnetic beads to oil droplets, from continuous to digital microfluidics, from optofluidics to electrokinetics, from developing to developed world, and the list goes on…
If your company isn’t on this list yet and you would like to add it, please click the button below to fill in the short form and be displayed below.
Add my company
Description: 1CellBiO Inc. researches, develops and commercializes innovative high throughput solutions for single cell genomics analysis. Our first product is inDrop, a high throughput method for single cell expression profiling from 100 to many tens of thousands of cells.
Description: 1Drop Diagnostics combines the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.
Description: 10x Genomics, Inc. is an American company that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics.
Description: AbCellera Biologics Inc. offers development of antibody therapeutics to improve patient outcomes. It provides microfluidic single cell analysis including cell culture, protein analysis, and single cell genomics.
Access Sensor Technologies
Description: Access Sensor Technologies specializes in product research and development in the field of environmental diagnostics.
Description: Achira Labs Pvt. Ltd. is start-up in the are of medical diagnostics which is developing proprietary lab-on-chip platforms to deliver medical affordable testing closer to the patient.
Advanced Liquid Logic
Description: Advanced Liquid Logic, Inc is committed to the development of cost-effective automation solutions for complex bioassay workflows.
Description: Ajuvis focuses on science and clinical studies with the use of specific bacterial strains and they’re interactions with various human health systems.
AI Biosciences, Inc.
Description: AI Biosciences (AIBI) is an early-stage company that develops rapid, low-cost, and simple-to-use technologies that will enable point-of-care (POC) molecular diagnostics with high sensitivity and specificity.
Description: Alvéole develops innovative tools to control the cell microenvironment, thus allowing biologists to control the development and proliferation of living cells in culture.
Description: AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
Description: AmberGen commercializes pioneering photonic technology developed at Boston University’s Molecular Biophysics Laboratory & the Photonics Center.
Description: Combines microfluidic lab-on-a-chip technology with physiologically relevant multicellular spheroids to enable formation and long-term culture of 3D tumor models for drug screening and individualized chemosensitivity testing.
Description: Ananda offers unique silicone microfluidic devices that enable scientists to increase standardization, precision, and reproducibility of cellular assays.
Antigen Discovery Inc.
Description: Antigen Discovery Inc. provides research services and products specializing in high throughput protein microarray technology that simplifies proteomic biomarker discovery and enables serological and immune profiling of whole proteomes.
Apollo Medical Devices
Description: Apollo Medical Devices is developing a disposable slide that uses a single drop of blood to provide a patient’s metabolic snapshot at the point-of-care.
Aptitude Medical Systems, Inc.
Description: Aptitude unlocks the potential of aptamers to solve the fundamental problems of antibodies.
Description: Aratome, LLC is a privately-held company founded by Stephen Smith, Kristina Micheva, Jay Trautman, Jonathan Ross, and Andy Blatz to develop commercial applications for the Stanford University invention of Array Tomography.
Description: Arborsense, Inc. is a technology startup spun out of the labs of University of Michigan Ann Arbor in 2015 with a vision to become the dominant player in wearable alcohol monitoring technology.
Description: We improve indoor air quality providing a healthier, more comfortable environment. Our core technology uses a scalable microfluidic chip to support the photosynthetic process – converting CO2 into Oxygen.
Description: Based on the combination of Nano, Biotech, IT and Cognitive Sciences Aryballe Technologies develops and supplies Innovative technologies, databases, software and devices applied to the identification, measurement and representation of smells and tastes.
Ascent Bio-Nano Technologies, Inc.
Description: We are a research spin-off from the Pennsylvania State University formed in 2012. Our Passion is to commercialize world leading acoustofluidic technologies to advance research, enhance health and improve life quality.
Description: Astraveus have developed an innovative microfluidic bioprocessing unit for the automated production of cell and gene therapies.
Description: ATACAMA is the world’s first moisture-channeling technology that integrates with flexible substrates (knits/wovens/nonwovens) to create dryer, lighter, and more breathable products.
Description: Athelas develops and manufactures blood analysis device to diagnose infections, inflammations and malignancies. The Company utilizes deep learning and computer vision to rapidly analyze tissue samples for diagnostics.
Ativa Medical Corp.
Description: Ativa Medical Corporation develops and commercializes point of care testing medical diagnostics products for decentralized healthcare settings.
Description: We have commercialized a unique benchtop model of the human nervous system as a more accurate, less expensive, and faster alternative to animal testing.
Description: Baebies, Inc. develops a bioassay automation/digital microfluidic platform to perform multiplex enzymatic assays and other tests in newborns.
Base Pair Biotechnologies Inc.
Description: Base Pair Biotechnologies, Inc. offers rapid discovery of high quality aptamer (DNA- and RNA-based) affinity ligands.
Berkeley Lights, Inc.
Description: Berkeley Lights, Inc. provides technology solution for single cell identification, measurement and manipulation for biopharma, diagnostics, and life science research.
Description: Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer.
Description: BioCopy develops a faster process for finding vaccine candidates, preferably reducing the time needed therefor from months to merely ’48 hours’.
Description: BioDetection Instruments develops and commercializes biosensors, assay kits, and instruments for rapid detection of food pathogens and chemical residues.
Description: BioFluidica is a privately held biotechnology company that has developed a diagnostic platform allowing for disease management and diagnosis through prognosis, all from a simple blood test.
Biological Dynamics, Inc.
Description: Biological Dynamics, Inc. is a San Diego based molecular diagnostic company with a primary focus on oncology. Biological Dynamics’ novel lab-on-a-chip platform uses the company’s proprietary ACE technology to isolate and analyze cell-free nanoparticles and macromolecules directly from biofluids.
Description: Our mission is to improve the quality of people’s lives by providing innovative solutions for infectious disease diagnosis. We research, develop and commercialize rapid, point-of-care in vitro medical diagnostic devices.
Description: BioMedomics develops point-of-care (POC) diagnostics, with a focus on immunologically-based disease-specific tests and advanced quantitative POC platforms.
Description: BioMensio Ltd., a biotechnology company, develops smart multi-analyte handheld detection devices for bio-analytics.
Description: Biomillenia develops non-GMO microbe strains and microbe-derived ingredients based on its unrivaled technology from the world’s leading microfluidics and genomics institutes.
Biond Solutions (BI/OND)
Description: BI/OND aims at providing biologists with customizable Organ-on-Chips (OOCs) built to outperform the limitations of standard in vitro assays. Our young and enthusiastic team is ready to use their expertise in silicon and polymer microfabrication to adapt our versatile platform to your needs.
Description: The company is focused on bringing quantitation to rapid point-of-care testing, allowing earlier and precise treatment that will benefit patients in developing countries and worldwide.
Description: BioSpyder is a molecular profiling company engaged in the development and commercialization of TempO-Seq technology, a novel expression profiling assay platform for measuring DNA, RNA and Proteins.
Description: bioSyntagma enables solutions to the big questions of the life sciences at a scale and scope unmatched by any other technology. Our technology is indispensable for advancing scientific knowledge and the successful clinical treatment of cancer, diabetes, neurological disorders, and auto-immune diseases.
Description: BluSense is a spin-off from the Department of Micro- and Nanotechnology, Technical University of Denmark. Its technology enables the accurate diagnosis of dengue and zika using a single drop of blood.
Description: BreviTest Technologies, LLC develops and manufactures point-of-care devices that are capable of replicating labor-intensive laboratory enzyme immunoassays.
Description: Briefcase Biotec develops life science equipment reduced to the bare essentials. It is one of six graduates of the first accelerator program for synthetic biology: Indie.Bio.
Butterfly Network, Inc
Description: Butterfly Network develops handheld semiconductor-based ultrasound systems.Butterfly Network’s Ultrasound-on-a-Chip™ technology modernizes ultrasound by delivering unparalleled diagnostic versatility at a price any clinician can afford.
Description: Capsum is a scientific company whose aim is to innovating in the cosmetic field. Our ambition is to bring breakthrough solutions by daring to change the way products are made and manufactured with the use of microfluidics technology.
Description: We develop systems that give accurate sugar analysis, simply and quickly, for the BioFuel, Brewing & Distilling, Food Processing and Pharmaceuticals industries.
Description: Carterra offers high throughput label-free analysis platforms for biomolecular interaction analysis. Founded in 2005 and based in Salt Lake City, UT, Carterra is developing the next generation of label-free biosensors for drug discovery and life science research.
Description: CBio is a hardware company leveraging machine vision and our proprietary cell analysis platform to accelerate solutions in AgTech, BioTech, CleanTech, and Defense. Our technology helps researchers studying live cells make better decisions.
Description: We create complex biological cell culture systems applying our proprietary STL-based bioprinting platform. Cellbricks’ vision is to help improving human health by bringing synthetic organs to reality.
Description: Celldom has developed a platform for massively parallel pharmacogenomics to computerize biology by unmasking cellular heterogeneity. This platform has immediate touch-points in drug discovery and development, and future clinical applications.
Description: Cellesce is developing technology to use cells from cancer biopsy to generate and grow organoids in 3D that can be used to screen available drugs (and combinations) and identify the optimum treatment. This development work builds on advances in microfluidics and ‘organ-on-a-chip’ technology.
Description: CellPly is a life-science company that develops in-vitro diagnostic platforms supporting personalized cancer treatment. Leveraging on a patented microfluidic technology, highly-integrated cell processing and analysis methods are supported and drug testing in the clinical setting is enabled with a high degree of automation and standardization.
Description: Celsee Diagnostics offers a fully automated circulating tumor cell (CTC) detection system that has the ability to analyze biomarkers at a single-cell level.
Charlot Biosciences, Inc.
Description: Charlot Biosciences has pioneered biomarker discovery platforms that enables researchers to identify markers for early detection of disease. Our propriety Intrepid Microfluidics™ platform enables the study of living cells. Our technology identifies important differences between Normal and Abnormal living cells, preserves function, and retains usability for further study.
Description: Circulomics is a Maryland biotechnology company located within Johns Hopkins’ FastForward Business Accelerator. The company develops innovative platforms for nucleic acid sample preparation, microRNA profiling, and single molecule analysis.
Description: Clinical Sensors is commercializing sensors to improve monitoring and care for serious medical conditions such as diabetes, chronic wounds, and infection.
CN Bio Innovations
Description: CN Bio develops human organ-on-chip technologies: devices that enable the formation of miniature models of human organs in the lab.
Description: Combinati is developing integrated digital PCR platform with a micromolded siphoning array.
Description: Correlia Biosystems is creating next generation proteomic technology that integrates complex assays such as ELISA or other immunoassays into rapid, automated and portable platforms for pharma and diagnostic use.
CrossLife Technologies Inc.
Description: CrossLife Technologies is a life sciences company founded with the mission of alleviating suffering and improving health through the development and commercialization of innovative molecular diagnostics for infectious diseases and non-communicable diseases.
Description: CYBO is an engineering company that develops and provides tools for scientific discovery that address the true complexities of biology at single cell resolution. Through a combination of advanced optics, electronics, microfluidics, mechanics, and computer science.
Description: CytoBioscience provides complete automated patch clamp solutions that enable you to successfully achieve your research and screening goals quickly and efficiently.
Cytolumina Technologies Corporation
Description: Company is working on CTC purification system based on thermoresponsive nanosubstrates.
Cytomics Analytical, LLC
Description: Detecting early-stage cancers with Blu-ray disc – detection, quantitation and analysis of extracellular vessicles using reflective phase grating technology.
Description: Cytonome is a biotechnology engineering and manufacturing company that designs and develops cutting edge cell sorting platforms. We offer powerful application-specific technology for the cell therapy, life science and industrial markets.
Description: CytoVale is an early stage life sciences company based in the San Francisco area. We are commercializing microfluidic technologies that enable high throughput single cell analysis.
Description: Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Company is developing of a microfluidic point-of-care HCV viral load assay.
Day Zero Diagnostics
Description: At DZD, we are developing a molecular diagnostic that uses high throughput sequencing and computational techniques to identify, within hours, both the species and the antibiotic resistance profile of a pathogen.
Description: We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis.
Deep Cell Industries
Description: DeepCell™ is a technology development company focusing on material science, microfluidics, and cannabinoid molecule discoveries.
Description: Deurion is a privately held company with expertise is in Biological Mass Spectrometry, Bioinformatics, and Microfluidics.
Diagnostic Biochips, Inc.
Description: Diagnostic Biochips, Inc. provides a chemical sensing technology for use inside the body. It offers a target-independent platform for continuous in vivo monitoring.
Description: Diassess produces inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.
Description: By integrating engineering and proprietary chemistries, Drawbridge is developing a people-friendly system for collecting and stabilizing blood samples, opening new doors to enable access to important health information.
Description: DropGenie automates precise liquid handling to amplify the thrill of discovery, via a digital microfluidics platform.
Description: Dropletex specializes in manufacturing microfluidic droplet generators for applications in molecular biology, microparticle synthesis, and microorganism studies. The company manufactures easy to use chips that are capable of generating a wide range of droplet size with high monodispersity.
Description: DST specialises in the development of innovative immunodiagnostic products for various health conditions. Company offers services for the development of ELISA kits, Line Immuno Assays (LIAs), multiplexing, lateral flow and microfluidics based tests for laboratory and Point-of-Care (POC) diagnostics.
Eccrine Systems, Inc.
Description: Eccrine Systems, Inc. Is developing non-invasive, electronic wearable systems that measure and transmit real-time data about human sweat.
Description: Ecomo is a smart water quality analyzer, powered by our patent-pending microfluidics mini spectrometry sensor, which collecting water quality data to optimize treatment process.
EfA - Engineering For All
Description: A product portfolio company for designing and delivering a world-class, affordable, scalable and sustainable medical solutions to the mass.
Description: Based on disruptive technology called “reprogramming”, Elpis provides differentiated human cells and tissue models for science, drug discovery, and toxicology.
Description: We work at the intersection of design, biology and engineering – developing new technologies, products & applications that emulate living human biology. Organs-on-Chips.
Description: Emultech is a high tech company that helps pharmaceutical organizations with more efficient drug delivery, in order to contribute to a better quality of life. We specialize in microsphere development using microencapsulation in microfluidics.
Description: Enable Injections develops and manufactures devices that allow patient self-administration of high volume/viscosity drugs. The Enable enFuse technology is a discreet body-worn device that provides a comfortable infusion experience allowing the patient to continue with normal daily activities.
Description: Encodia is developing new technologies to create scalable and parallelized approaches to protein analysis. Our goal is to enable breakthrough proteomics research which is simply not practical or cost-effective using current technologies.
Description: Engender Technologies has created a new microfluidic and photonic technology to sort livestock sperm by sex to enrich X chromosome-bearing bull sperm cells.
Description: EnLisense is a sensor device company focusing on consumer and healthcare. EnLiSense’s SWEATSENSER Dx platform technologies enable acute and chronic disease monitoring across both clinical and consumer space.
Epicore Biosystems, Inc.
Description: Epicore Biosystems, Inc. has developed a proprietary sweat microfluidic sensing platform that is ‘skin-like’, low-cost, and capable of analyzing small droplets of sweat directly from the skin.
Description: EvolveMol rapidly evolves microorganisms to produce small molecules for the bioenergy and pharmaceutical industries. Our aim is to create organisms capable of realizing this vision.
Faraday Technology Inc.
Description: Faraday Technology is working on the development of microfluidic system for CO2 reduction to hydrocarbons in microgravity.
Description: Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised, allowing our customers to understand the machinery of life.
Description: Fluidion is an innovative high-technology company providing autonomous in-situ sampling and measurement solutions for environmental monitoring and water quality applications: sample collection, chemical measurements, microbiological analysis.
Description: Fluid-Screen is a startup company spun out of Dr. Mark Reed’s lab at Yale University. Fluid-Screen integrates four core technologies into a portable device for rapid bacteria detection.
Description: Company develops wirelessly operated implantable micropump for on-demand drug administration in laboratory animals.
Description: Fluxion Biosciences, Inc. develops analytical instruments for functional cellular analyses in life science, drug discovery, and diagnostic applications.
Description: GenapSys is enabling a new era of genomic testing and a new paradigm of how we engage the molecular world. We are developing a cost-disruptive, easy-to-use DNA sequencing device.
Description: GeneFluidics develops a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano and microfluidic technologies, the company’s revolutionary platform enables complex tests that are normally performed only by skilled technicians in a laboratory to be performed by anyone, anywhere.
Description: GenePOC Inc. is a privately owned company that develops cost-effective and rapid molecular devices to detect pathogen genes at Point-of-Care (POC).
Description: Genomtec developed the lab-on-a-chip analyser that fits into your pocket that and needs just 20 minutes to detect the presence of DNA or RNA in a genetic sample, identifying viruses, bacteria, genetic mutations and fungi without the need to consult a specialist.
Description: GigaGen operates as a pre-clinical biotherapeutics company. Its platform uses microfluidics, bioinformatics, sequencing, and genetic engineering to mine B and T cell repertoires for full length natively paired antibodies and T cell receptors (TCRs).
Description: Glauconix™ is the leading developer of ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery.
Description: Utilizing emulsion microfluidics, GnuBIO has been able to create a scalable DNA sequencing reaction which encompasses all of the steps necessary for DNA sequencing inside of tiny picoliter-sized aqueous drops.
Description: GPB has the best solution for obtaining rare circulating tumor cells (CTCs) from the patient’s blood, a “liquid biopsy:” providing the missing link in precision diagnosis, prognosis and treatment.
Group K Diagnostics
Description: Group K is developing a point-of-care diagnostic device that leverages paper-based microfluidics technology to reduce cost and time of testing for over 40 diseases.
Description: Haemair provides support for people with lung disease or injury. Its technology takes part of the blood circulation and passes it through an “artificial lung” to oxygenate the blood and remove carbon dioxide.
Description: HaptX (formerly AxonVR) introduces the world’s first industrial-grade haptic gloves. Patented microfluidic technology physically displaces the skin the same way a real object would when touched, closely replicating its texture, shape, and movement.
Description: HemoSonics operates as a medical device company that develops and commercializes a point-of-care diagnostic instrument to guide the management of critical bleeding in surgery and acute care settings.
Description: Hesperos aims to optimally characterize individual human biology through innovative human body-on-a-chip technology for toxicological and efficacy testing.
HiFiBiO - High Fidelity Biology
Description: HiFiBiO SAS commercializes proprietary single cell technologies for applications in drug and biomarker discovery and development.
Description: Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. The primary focus of Hooke bio is on drug combinations.
Immuno Technologies, Inc.
Description: Immuno Technologies focuses on applied research for infectious diseases. With our main focus in Lyme disease and Leptospirosis we develop diagnostic assays and prophylactic/ preventive agents (vaccines) to help mitigate the impact of these diseases in human health.
Description: ImpeDx Diagnostics has secured exclusive rights to develop and market a novel system for rapidly detecting bacteria in blood culture specimens for use in clinical laboratories.
Description: Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacturing of gene-modified cell therapies. Gene delivery via microfluidic vortex shedding enables fast processing of small and large volumes of human primary immune cells.
Description: InnaMed is developing a connected blood testing platform to improve post acute care.
Description: Innosense is a research organization that is developing innovative products using advanced materials and sensor research.
Description: INITIO designs and produces patent pending multi-functional lab-on-a-chip devices for 2D and 3D cell culture.
Description: Inito is a medical technology company building the next generation of portable diagnostic devices that are not just accurate and reliable, but are also smart and easy to use. Our proprietary technology allows a single device to perform dozens of diagnostic tests at home making people happier, healthier and more productive.
Description: Innolyzer Labs develops and manufactures lab-on-a-chip devices used to detect the quantity of hydrogen sulfide in scientific, clinical, water, waste water, and oil and gas applications.
Description: Innoture holds worldwide patents enabling the company to adopt a unique position in the manufacture, development and commercialisation of microneedle technologies.
Description: iBioChips integrate diagnostic assays and cellular engineering into miniaturized chips and achieve cutting-edge sensitivity and throughput.
Description: The company is developing point-of-care (PoC) and near patient platforms for the delivery of low cost, high-performance, and mass-deployable solutions for DNA and protein-based diagnostic testing.
Description: InSphero provides advanced, yet easy-to-use 3D cell-culture-based solutions for drug discovery and development. Our organotypic human- and animal-derived models offer superior biological relevance for in vitro compound testing.
Description: Instadiagnostics Inc. is developing a rapid, quantitative, point-of-care, diagnostic technology platform with the diagnosis of liver cancer as the first application.
Description: Interface Fluidics is an engineering laboratory service company specializing in microfluidics for oil and gas with headquarters in Calgary.
Description: Intabio, Inc. develops Blaze system, a bench-top instrument, microfluidic chip, and reagent kit for separation, quantitation, and molecular mass identity analysis. The company also develops a microfluidic platform to provide real-time and direct characterization of intact protein isoforms to identify the specific modification.
Description: Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.
Description: IsoPlexis, a venture-backed Yale-spinout company, is developing a diagnostic platform to accelerate immunology research and therapeutic development.
Description: Jan Biotech, Inc’s intellectual properties include novel molecular in vitro assays for clinical diagnosis and quantification of latent infections such as HIV-1, as well as detection of aggressive cancer (ex., prostate) and cancer treatment monitoring.
Description: Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The company’s genomics platform uses a combination of machine-learning, proprietary signal processing algorithms, and next-generation sequencing to enable the broad and rapid detection of microbial cell-free DNA through a standard blood draw.
Description: Klearia is a spin-off of the CNRS that develops high value-added glass microfluidic devices also called “lab-on-a-chip” dedicated to researchers working in the field of flow chemical synthesis or analytical chemistry.
Koronis Biomedical Technologies (KBT)
Description: KBT’s core capabilities include ultra-miniature electronic design, firmware and algorithm development, and sensor research. Company is developing rapid POC toxin assay using aptamer-functionalized magnetic nanoparticles
Description: Kytopen, accelerating the development of genetically engineered cells by developing technology that modifies microorganisms 10,000 times faster than current state-of-the-art methods.
Leiden Measurement Technology
Description: Company is developing a portable microfluidic instrument capable of measuring inorganic ions in potable water supplies, thermal control system cooling water, and even human waste water.
Description: LeukoDx delivers highly sensitive and actionable diagnostic information at the point of care via a novel automated IVD flow cytometry platform based on microfluidics technology.
Description: LexaGene develops a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.
Linear Diagnostics Limited (LDL)
Description: Linear Diagnostics is a diagnostics company developing a microfluidic cartridge-based platform to detect multi-drug-resistant bacteria in hospitals.
Description: Loonskin Labs is a manufacturing startup company that uses material processes to mimic biological structures in fluid mediums. We grow vasculature into silicone membranes to regulate the temperature on and apply pressure to surfaces.
Description: Lunavation develops low-voltage pumps and separation systems for use in lab-on-a-chip devices.
Description: LynxBio is is developing technologies enabling the prediction of clinical treatment response for multiple myeloma (MM) and other blood cancer patients.
Description: MassTech is an analytical instrumentation and technology company developing microfluidic-based device for ambient mass analysis.
Description: Company develops and markets advanced electrophysiology platforms for cell assays in preclinical drug discovery, safety pharmacology and basic neuroscience research.
Description: mFluiDx, Inc. manufactures a diagnostic chip that enables molecular detection to diagnose infectious diseases.
Description: MicroBrain Biotech develops and designs microfluidic devices and Nerve-on-Chip (reconstructed neuron networks at the micron scale).
Description: It is a limited liability company that commercializes blood related research developed by Dr. Adrienne Minerick at Michigan Technological University. Company is developing microdevice for rapid blood typing without reagents and hematocrit determination.
Description: Micro-gRx was founded to adapt and enhance life sciences disease modeling technologies for use in space.
Description: MicroMedicine is a life sciences technology startup commercializing a patented microfluidics-enabled cell separation platform with transformational applications in research, diagnostics, and therapeutics.
Description: MicroOptx is an early stage medical device company that leverages academic bioengineering, surgical expertise, micro engineering manufacturing and nano technology to provide the modern solution for the vexing problem of Glaucoma
Description: MicroX Labs currently focusing on technological platform to make affordable and accurate point-of-care diagnostics devices, starting with the most common diagnostic – Complete Blood Count (CBC) test.
Description: The company focuses on development of microfludics and lab-on-a-chip systems for biomedical applications including Multi-Drug-Resistance (MDR) and Circulating Tumor Cells (CTC) detection for early diagnosis and prognosis of cancer.
Mirada Technologies Inc.
Description: Mirada Technologies Inc. develops and sells LiDAR sensor components for autonomous vehicles and advanced driver safety systems to automotive suppliers. Mirada has invented an ultra low cost, high performance laser beam steering technology based on microfluidics.
Description: Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Mission Bio, Inc.
Description: Mission Bio, Inc. develops and delivers tools for the study of cellular heterogeneity in human health and life science research. It relies on microfluidic droplet technology to deliver solutions for molecular analysis of single cells.
Description: Company develops a product that will provide unique opportunity to populations to test their water for safety and health benefits, in locations where good water treatment facilities do not exist.
Description: Moirai Biodesign is a biotechnology company that develops RNA-based technologies for cancer-related diagnostics and therapeutics.
Description: MouSensor, Inc. is an early-stage biotech company that engineers super sniffer mice to build a live, human nose-on-a-chip with the bold vision to detect, discover and digitize every single smell on this planet; from the fragrances in a perfumer’s palette to the odors associated with diseases such as Parkinson’s.
Description: Nanna Therapeutics has developed a tightly integrated set of proprietary technologies that radically disrupt current methods of creating new medicines. This Totally Integrated Medicines Engine (TIME) has been devised to answer the needs of drug discovery and development scientists utilising the best in 21st century technologies of microfluidics, nanofabrication and artificial intelligence.
NanoCellect Biomedical, Inc.
Description: The company uses microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research.
Description: Nanōmix has developed a mobile, POC diagnostic system to provide rapid and actionable diagnostics in hospital and pre-hospital environments.
Description: Nanotis is developing quick diagnosis for influenza with a micro-chip and smartphone.
Description: nanoView Diagnostics Inc. enables simple detection of nanoparticles from complex samples like whole blood, serum, plasma, and urine.
Description: NemaMetrix’s flagship ScreenChip technology enables real-time discovery of drugs and its molecular mechanisms of action and toxicity.
Description: NeuMoDx Molecular operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.
Description: NeuroLux aims to provide revolutionary Discovery Tools for Neuroscience. Our cutting edge technology provides the best solution for optogenetic simulation in freely moving animals. NeuroLux’s super light weight optogenetic devices are fully implantable and adaptable to any enclosure.
Description: Ben-Yakar’s startup company, Newormics, is working to develop a design of new platform for roundworms that could speed up drug delivery for a commercial product that could be cheaply and easily manufactured.
Description: Nivarta is a discovery stage biopharmaceutical company that is focused on treating rare metabolic diseases, diabetes, and obesity.
Description: Nodexus is a UC Berkeley/Stanford StartX company commercializing technologies to address cutting-edge workflows in gene editing, cancer biology, agriculture, and more.
Description: Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of human micro tissue environment within small, disposable, microfluidic chips.
Description: Our ADEXUSDx® product line features a lab at your fingertip, using a drop of blood to test for a variety of conditions, illnesses, and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOW Diagnostics has the potential to dramatically decrease the waiting period to determine test results.
ODMR Technologies, Inc.
Description: ODMR Technologies Inc is a small start-up company developing a nanophotonic magnetic-resonance spectrometer for chemical trace analysis.
Optofluidic Bioassay, Inc.
Description: Optofluidic Bioassay is the developer and manufacturer of a novel, microfluidic 96-well ELISA plate that improves workflow, decreases assay time, and maintains assay performance with less sample and reagent volume.
Orbis Diagnostics Limited
Description: Orbis Diagnostics is developing in-line milking measurement for protein, fat, somatic cell and progesterone.
Description: Orphidia Inc. is developing a unique application of microfluidics that enables automation and miniaturization of traditional blood testing processes.
Description: Oxford HighQ is a spinout from the University of Oxford’s Departments of Materials and Chemistry that will produce next generation chemical and nanoparticle sensors that offer a step change in fluid-based sensing across a wide range of applications and markets.
Description: This is a specialty pharmaceutical company focused on developing innovative drugs for the treatment of central nervous system (CNS) inflammatory disorders including Frontotemporal Dementia (FTD) and Alzheimer’s disease (AD).
Phase Scientific International Limited
Description: Founded by scientists at the University of California, Los Angeles, Phase Scientific International Limited is a fast-growing biotech startup developing cutting-edge technologies that we believe will change the landscape in diagnostics and healthcare management.
Description: PHASIQ, Inc. provides immunoassay kits and custom assay development to research scientists investigating protein biomarker patterns for human health.
PixCell Medical Technologies
Description: Company develops, produces, and markets portable medical diagnostic products for point of care testing. PixCell’s products are based on its innovative Viscoleastic Focusing (VEF) technology and single use cartridges that enable rapid, accurate and simple blood sampling and analysis.
Description: Platelet BioGenesis, Inc., a biotech company, produces commercial scale donor-independent human platelets from pluripotent stem cells for clinical application. The company develops a microfluidic bioreactor that is used to generate functional platelets from human stem cell cultures at scale.
POC Medical System, Inc
Description: POC Medical Systems Inc. engages in the development of a breast cancer screening tool for diagnosis. It develops Point-Of-Care testing that is performed near the site of the patient for timely response in patient care.
PolyPico Technologies Ltd.
Description: PolyPico Technologies is commercialising and award winning patented technology utilising acoustic energy for non contact, Ultra Low Volume fluid dispensing utilising a disposable cartridge that avoids cross contamination and cleaning equipment and processes.
PreDxion Bio, Inc.
Description: PreDxion Bio is a precision medicine company seeking to fundamentally change critical care and emergency medicine. Using breakthrough technology and novel biological insights, PreDxion Bio enables lifesaving therapies for the sickest patients.
Description: Company is developing point of care device for high frequency stratification of patient populations at risk of sepsis.
Description: Protein Fluidics is commercializing new microfluidic systems for bio-sample analysis in order to accelerate data driven decisions. We are passionate about providing scientists with the latest technologies to help them create the next generation of therapeutics.
Description: Purigen Biosystems, Inc. develops a technology platform for extracting, enriching and quantifying DNA and RNA from biological samples.
Description: Qatch Technologies develops microfluidic sensor technology to measure blood coagulation in point-of-care diagnostic tests.
Quantitative BioSciences, Inc.
Description: We are developing biosensor technologies that use microfluidics along with engineered microbes to continuously monitor water for targets of interest.
Description: Application of quantum mechanics to the development of innovative single-molecule DNA sequencers.
Description: RAB-Microfluidics is a Research & Development company developing cutting-edge microfluidic technology to solve oil analysis problems.
Radiant Genomics, Inc.
Description: Radiant Genomics is developing a synthetic biology platform that provides industrially scalable access to the chemistry encoded by natural organisms.
Description: RainDance Technologies, a life sciences company, provides microdroplet-based solutions for the early detection of cancer and other diseases.
Description: RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.
Description: Intelligent point-of-care screening to combat the antibiotics crisis.
Description: Rheonix develops automated molecular testing solutions for interchangeable purification, amplification and detection.
Description: rqmicro AG develops and markets proprietary reagents and innovative instruments for rapid microbiological tests in water and food. rqmicro uses the great potential of microfluidics to deliver a product that allows for a highly efficient separation of target from any sample matrix, using immunomagnetic separation (IMS).
Sandstone Diagnostics, Inc.
Description: Sandstone Diagnostics is a biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home.
Scaled Biolabs Inc.
Description: Scaled Biolabs is accelerating biologic, gene, and cell therapies using smart microfluidic chips. Their flagship Microbioreactor Array technology turbocharges cell culture and cell-based assays, which are cornerstone techniques in any in vitro lab.
Description: Project: SoilCards are paper tests that make soil-nutrient analysis easy, quick, and affordable to smallholder farmers who don’t have access to soil-testing laboratories.
SciKon Innovation, Inc.
Description: We are a biotechnology company that has developed an in-vitro fluidics cell culture system with flow which has demonstrated several benefits over existing static models.
SeLux Diagnostics, Inc
Description: SeLux Diagnostics is developing novel platform for improving access to and efficacy of fertility treatments.
Description: SenGenix develops point-of-care blood diagnostic tests using bioengineered fluorescently-responsive sensors. Testing is done with a finger-stick, and results are available immediately.
Description: SensoDx specializes in development of state-of-the-art multi-parameter point-of-care diagnostic solutions that relay test information directly to patients and healthcare providers using intuitive mobile health (mHealth) interfaces.
SFC Fluidics Inc.
Description: SFC Fluidics develops miniaturized analytical and diagnostic platforms using microfluidic and detection technologies. Its products are used in point-of-care diagnostics, analytical instrumentation, and laboratory liquid handling markets.
Shaw Mountain Technology
Description: Shaw Mountain Technology is a small business that specializes in shape memory alloys, particularly the magnetic shape memory alloy Ni-Mn-Ga, and develops various technologies within the fields of sensors, microfluidics, energy harvesters and actuators.
Description: Sight Diagnostics, an Israeli medical devices startup that’s using computer vision and machine learning technology to speed up blood testing, is launching a point-of-care blood diagnostics system today.
Singularity Sciences Inc.
Description: Singularity Sciences is developing a revolutionary lab-on-a-chip technology for panel-based, low-cost, on-site diagnostics. Our device will be fully patient operated, only require several drops of blood and provide clinically accurate results in minutes.
SOMAVAC Medical Solutions, Inc
Description: SOMAVAC creates a solution for the management of post-surgical fluid accumulation and the prevention of seroma, a condition that occurs after large flap surgery where fluid accumulates in the dead space between tissue.
Southwest Sciences, Inc.
Description: We specialize in the development of state-of-the-art optical and mass spectrometric technologies and the extension of these technologies into the marketplace.
Spectra Solutions Inc.
Description: Spectra Solutions is developing micofluidic spectroscopic sensor for nuclear fuel reprocessing solutions.
Description: Spectradyne designs and manufactures high resolution nanoparticle analysis instrumentation for the biotech, pharmaceutical, and materials industries.
Description: We develop novel single cell analysis systems for scientists searching for rare and valuable biological variants across research, therapeutic, bioproduction and diagnostic applications.
Description: Spheryx operates as an analytical services and instruments company for food, instruments, consumer products, medical diagnostics, quality assurance, and manufacturing process control applications.
Description: SpinDiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for drug-resistant pathogens.
Description: Spun out of MIT, SQZ Biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient’s immune system to combat disease.
Description: During the past two years, Stämm has designed a novel bioproduction system that leverages microfluidics, electroporation and robotics to solve the main constraint of the biotech industry: scaling up. We downsized a whole biotech plant into an all-in-one, plug-n-play desktop unit: the Bioprocessor.
Stasys Medical Corporation
Description: Stasys Medical is a Seattle based company developing a system to rapidly identify blood clotting deficiencies and provide relevant, actionable information to caregivers.
Description: Stemnovate delivers innovative drug-screening and safety-testing platforms. Our user-friendly, flexible platforms overcome the limitations of mammalian cell-lines and in-vivo models commonly used in drug-discovery.
Syntr Health Technologies
Description: Syseng is developing a computational tool for modeling, simulation, and design of next generation discrete droplet microfluidic systems.
Description: TacSense has developed the world’s first microfluidic interfacial capacitive sensors (MICS), utilizing novel interfacial microfluidic and iontronic detection principles.
Talis Biomedical Corporation
Description: Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings.
TARA Biosystems, Inc.
Description: The company develops its organ-on-a-chip platform to provide physiologically relevant heart-on-a-chip human tissue models for toxicology and new drug discovery applications.
Description: Leveraging proprietary microfluidic technology within our device, we have designed an elegant system that collects blood at the push of a button.
Tide Microfluidics B.V.
Description: Our innovative platform technology used for the production of monodisperse microbubbles and microparticles is based on microfluidic techniques.
Description: TissUse provides a range of products which feature miniaturized constructs that closely simulate the activity of multiple human organs in their true physiological context at the smallest possible scale.
Description: Transgenex Nanobiotech, Inc., a biotechnology company, engages in the discovery and development of nanoparticle formulations and nano-encapsulation methods for the treatment of acute and chronic lung diseases and cancers.
Description: Travera is using a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells. We are developing a universal biomarker for enabling oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients’ tumor cells to candidate drugs.
Description: uFluidix is a contract manufacturer that designs, develops, and fabricates custom microfluidic chips that are mainly used by medical devices, diagnostics, and therapeutics companies for a variety of microtechnology applications.
Description: uFraction8 specialises in applying microfluidics at scale. Initially focused on dewatering applications, uFraction8 will diversify into environmental monitoring and water treatment in the near future.
Description: Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Description: UniDx is a universal drop-based microfluidics platform for low-cost, rapid, and early diagnosis.
Description: We developed a fast and low cost diagnostic and disease surveillance technology for infectious diseases which allow doctors, nurses and community health workers to diagnose diseases directly on the point of care, in less than 15 minutes, without the use of any lab equipment in three simple steps.
Description: Biotech start-up with a novel protein conjugation platform. We are giving you chemical handles specifically placed into your protein for you to make a connection precisely where you want to.
Description: Company is working on the development of terahertz frequency spectrometer combined with sub-wavelength microfluidic platform.
Description: Vortex Biosciences is the innovation leader in CTC capture technology developing a liquid biopsy technology for cancer diagnosis and monitoring.
Wave 80 Biosciences
Description: Wave 80 Biosciences, Inc. develops molecular diagnostics instruments and consumables for hepatitis C, hepatitis B, HIV/AIDS, infectious diseases, cancer, autoimmune diseases, and other human health conditions.
Description: As a platform technology, the ClotChip™ sensor from XaTek is agnostic to the cause of the bleeding disorder and is therefore uniquely situated to serve urgent needs of a number of medical different markets. The XaTek device is sensitive to the entire hemostatic process, including platelet disorders.
Description: Xona Microfluidics specializes in providing scientists a PDMS based microfluidic platform for neuroscience research. Company is developing a user-friendly scalable microfluidic platform for enhanced neuron-cell culture.
Description: Xsensio develops the unique Lab-on-Skin™ sensing platform for next-gen wearables. It senses in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
Xylyx Bio, Inc.
Description: Xylyx Bio specializes in cell-specific biomaterials. Rather than isolated components or synthetic materials, the Company’s suite of extracellular matrix-derived products provide the most physiological cell environment possible in which to create and deliver effective science-based solutions for the benefit of human life and health.
Description: Zansors makes wearable sensors and mobile apps to help you capture personal health information. Our proprietary biotechnology platform includes micro and nano sensors and microfluidics, backed by more than 90+ patents.
Zephyrus Biosciences, Inc.
Description: Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Company is developing microfluidic disposables and instrument for a single-cell western blotting system. Acquired by Bio-Techne.